Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Unfit Patients”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)UnknownNCT03809780
What this trial is testing

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
Kosin University Gospel Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Large-scale testing (Phase 3)UnknownNCT04490707
What this trial is testing

Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML

Who this might be right for
Acute Myeloid Leukemia in Remission
Ge Zheng 60
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Large-scale testing (Phase 3)UnknownNCT05179733
What this trial is testing

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Ruijin Hospital 280
Testing effectiveness (Phase 2)Study completedNCT01444716
What this trial is testing

Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 34
Early research (Phase 1)WithdrawnNCT04973618
What this trial is testing

Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

Who this might be right for
AML
Aptevo Therapeutics
Large-scale testing (Phase 3)Study completedNCT01237808
What this trial is testing

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 144
Large-scale testing (Phase 3)Study completedNCT06073730
What this trial is testing

Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients

Who this might be right for
Elderly AML PatientsUnfit, New-diagnosis AMLAcute Myeloid Leukemia+2 more
The Second Affiliated Hospital of Kunming Medical University 154
Testing effectiveness (Phase 2)Study completedNCT01810705
What this trial is testing

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloid Leukemia
ERYtech Pharma 123
Testing effectiveness (Phase 2)Study completedNCT03677154
What this trial is testing

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Hoffmann-La Roche 188
Testing effectiveness (Phase 2)UnknownNCT03949062
What this trial is testing

Study Evaluating the Safety and Efficacy of iR2 in Untreated and Unfit Elderly Patients With DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 30
Not applicableUnknownNCT02698124
What this trial is testing

Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice

Who this might be right for
Acute Myeloid LeukemiaElderlyIntensive Chemotherapy Unfit
Ulsan University Hospital 136
Large-scale testing (Phase 3)Study completedNCT01884623
What this trial is testing

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head Neck Cancer Squamous Cell Recurrent
Gustave Roussy, Cancer Campus, Grand Paris 82
Early research (Phase 1)UnknownNCT00636922
What this trial is testing

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07207785
What this trial is testing

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 56
Testing effectiveness (Phase 2)Looking for participantsNCT06387121
What this trial is testing

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)Looking for participantsNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Testing effectiveness (Phase 2)Ended earlyNCT05144009
What this trial is testing

Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
ADC Therapeutics S.A. 41
Testing effectiveness (Phase 2)UnknownNCT01488344
What this trial is testing

Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
University Hospital Muenster 140
Next Page